Radiation recall phenomenon secondary to bevacizumab in a patient with pancreatic cancer

Journal of the Pancreas

Volumn 9, Issue 6, 2008, Pages 744-747

  Saif, Muhammad Wasif ^a   Ramos, Jorge ^a   Knisely, Jonathan ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bevacizumab; Capecitabine; Fluorouracil; Gemcitabine; Hemorrhage; Pancreatic neoplasms; Radiodermatitis

Indexed keywords

BEVACIZUMAB; CAPECITABINE; GEMCITABINE; INFLIXIMAB;

ABDOMINAL PAIN; AGED; ASPIRATION BIOPSY; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CATHETER ABLATION; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG WITHDRAWAL; ENDOSCOPIC ECHOGRAPHY; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HUMAN; HUMAN TISSUE; LETTER; MONOTHERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS CANCER; RHEUMATOID ARTHRITIS; THROMBOCYTE COUNT; WEIGHT REDUCTION;

ADENOCARCINOMA; AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; ANTIMETABOLITES, ANTINEOPLASTIC; DEOXYCYTIDINE; DUODENITIS; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; PANCREATIC NEOPLASMS; RADIODERMATITIS; STOMACH ULCER;

EID: 56849102519     PISSN: None     EISSN: 15908577     Source Type: Journal    
DOI: None     Document Type: Letter

References (17)

1. Caloglu M, Yurut-Caloglu V, Cosar-Alas R, Karagol H, Uzal C. An ambiguous phenomenon of radiation and drugs: Recall reactions. Onkologie 2007; 30: 209-214.
2. Burnstein HJ. Side effects of chemotherapy. Case 1. Radiation recall dermatitis from gemcitabine. J Clin Oncol 2000; 18: 693-694.
3. Castellano D, Hitt R, Cortes-Funes H, Romero A, Rodriguez-Peralto, JL. Side effects of chemotherapy. Case 2. Radiation recall reaction induced by gemcitabine. J Clin Oncol 2000; 18: 695-696.
4. Jeter M, Pasi J, Brooks S, Burnstein HJ, Wen P, Fuchs CS, et al. Gemcitabine induced radiation recall. Int J Radiat Oncol Biol Phys 2002; 53: 394-400.
5. Fakih MG. Gemcitabine-induced rectus abdominus radiation recall. JOP. J Pancreas (Online) 2006; 7: 306-310.
6. Friedlander PA, Bansal R, Schwartz L, Wagman R, Posner J, Kemeny N. Gemcitabine-related radiation recall preferentially involves internal tissue and organs. Cancer 2004; 100: 1793-1799.
7. Saif MW, Sellers S, Russo S. Gemcitabine-related radiation recall in a patient with pancreatic cancer. Anticancer Drugs 2006; 17: 107-111.
8. Fogarty G, Ball D, Rischin D. Radiation recall reaction following gemcitabine. Lung Cancer 2001; 33: 299-302.
9. Schwartz BM, Khuntia D, Kennedy AW, Markman M. Gemcitabine-induced radiation recall dermatitis following whole pelvic radiation therapy. Gynecol Oncol 2003; 91: 421-422.
10. Vogl DT, Glatstein E, Carver JR, Schuster SJ, Stadtmauer EA, Luger S, Nasta SD, et al. Gemcitabine-induced pericardial effusion and tamponade after unblocked cardiac irradiation. Leuk Lymphoma 2005; 46: 1313-1320.
11. Schwarte S, Wagner K, Karstens JH, Bremer M. Radiation recall pneumonitis induced by gemcitabine. Strahlenther Onkol 2007; 183: 215-217.
12. Tan DH, Bunce PE, Liles WC, Gold WL. Gemcitabine-related "pseudocellulits": report of 2 cases and review of the literature. Clin Infect Dis 2007 Sep 1;45(5):e72-6. Epub 2007 Jul 20.
13. Johnson DH, Fehrenbacher L, Novotny WF et al. Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carbopaltin and paclitaxel alone in previously untreated locally advanced or metastatic non-small cell lung cancer. J Clin Oncol 2004; 22: 2184-2191.
14. Herbst RS, Sandler AB. Non-small cell lung cancer and antiangiogenic therapy: what can be expected of bevacizumab? Oncologist 2004; 9 (Suppl 1): 19-26.
15. Kindler HL, Friberg G, Singh DA, Locker G, Nattam S, Kozloff M, et al. Phase II trial of bevacizumab plus gemcitabine in patients with advanced pancreatic cancer. J Clin Oncol. 2005 Nov 1;23(31):8033-40.
16. Burstein H. Radiation recall dermatitis from gemcitabine. J Clin Oncol 2000; 18:693-994.
17. Saif MW, Black G, Johnson M, Russo S, Diasio R. Radiation recall phenomenon secondary to capecitabine: possible role of thymidine phosphorylase. Cancer Chemother Pharmacol. 2006 Dec;58(6):771-5.